Affirms Support for Fair and Equitable Dividend Distribution for All Shareholders by Sinovac . Corrects the Company’s Misrepresentations of Vivo’s Capital Contributions, Which Have Been ...

HOUSTON, April 21, 2025--Phillips 66 sent a letter to shareholders highlighting information for shareholders to make an informed voting decision at the Annual Meeting.

SAIF Partners IV L.P., ("SAIF Partners"), the largest single investor in Sinovac Biotech Ltd. ("Sinovac" or the "Company"), beneficially owning approximately 15% of the outstanding common shares, ...

HONG KONG, June 10, 2025--Prime Success L.P., (together with its affiliates, "Prime Success" or "we"), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company ...

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that its board of directors issued a public letter to shareholders in response to hostile actions ...

Phillips 66 today sent a letter to shareholders highlighting valuable information for shareholders to make an informed voting decision at Phillips 66’ s upcoming Annual Meeting on May 21, 2025.

Oversee a fair, equitable, and timely distribution of cash dividends, including fully supporting the payment of the announced dividend of approximately $55 per share to all shareholders, but also ...